Metabolism of thromboxane B2 in the monkey

Area of Science:

• Biochemistry
• Pharmacology
• Metabolomics

Background:

• Thromboxane B2 (TXB2) is a key product of the cyclooxygenase pathway.
• Understanding TXB2 metabolism is crucial for studying its physiological and pathological roles.
• Limited information exists on the specific urinary metabolites of TXB2 in vivo.

Purpose of the Study:

• To identify and elucidate the structures of urinary metabolites of Thromboxane B2 in an unanesthetized primate model.
• To characterize the metabolic pathways of TXB2 in vivo.

Main Methods:

• Biosynthesis and administration of radiolabeled [3H8]Thromboxane B2 to an unanesthetized monkey.
• Isolation and purification of urinary metabolites.
• Structure elucidation using gas chromatography-mass spectrometry (GC-MS).

Main Results:

• Identified dinor-thromboxane B2 as the major urinary metabolite.
• Elucidated structures of several novel TXB2 metabolites, including 11-dehydro-thromboxane B2 and its further oxidized/degraded forms.
• Identified 6-(1,3-dihydroxypropyl)-7-hydroxy-10-oxo-3-pentadecaenoic acid.
• Detected three mono-O-ethylated TXB2 metabolites due to the ethanolic infusion vehicle.
• Observed excretion of a small amount of unchanged TXB2.

Conclusions:

• The study successfully identified and characterized multiple urinary metabolites of Thromboxane B2 in vivo.
• Metabolism of TXB2 involves beta-oxidation, omega-oxidation, and dehydrogenation pathways.
• These findings contribute to a comprehensive understanding of TXB2 catabolism and its excretion products.